NZ520482A - Selective N-acylation of A82846 glycopeptide analogs that are ueful for treating staphylococcal infection - Google Patents

Selective N-acylation of A82846 glycopeptide analogs that are ueful for treating staphylococcal infection

Info

Publication number
NZ520482A
NZ520482A NZ520482A NZ52048201A NZ520482A NZ 520482 A NZ520482 A NZ 520482A NZ 520482 A NZ520482 A NZ 520482A NZ 52048201 A NZ52048201 A NZ 52048201A NZ 520482 A NZ520482 A NZ 520482A
Authority
NZ
New Zealand
Prior art keywords
ueful
acylation
selective
staphylococcal infection
treating staphylococcal
Prior art date
Application number
NZ520482A
Other languages
English (en)
Inventor
Richard Craig Thompson
Stephen Charles Wilkie
Mark James Zweifel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NZ520482A publication Critical patent/NZ520482A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NZ520482A 2000-02-11 2001-02-12 Selective N-acylation of A82846 glycopeptide analogs that are ueful for treating staphylococcal infection NZ520482A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18168300P 2000-02-11 2000-02-11
PCT/US2001/004540 WO2001058933A2 (en) 2000-02-11 2001-02-12 Selective n-acylation of a82846 glycopeptide analogs

Publications (1)

Publication Number Publication Date
NZ520482A true NZ520482A (en) 2004-12-24

Family

ID=22665319

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ520482A NZ520482A (en) 2000-02-11 2001-02-12 Selective N-acylation of A82846 glycopeptide analogs that are ueful for treating staphylococcal infection

Country Status (17)

Country Link
US (1) US7365053B2 (OSRAM)
EP (1) EP1254164B1 (OSRAM)
JP (1) JP2003522197A (OSRAM)
KR (1) KR100796079B1 (OSRAM)
CN (1) CN1422279A (OSRAM)
AT (1) ATE308560T1 (OSRAM)
AU (2) AU2001238180B8 (OSRAM)
BR (1) BR0108268A (OSRAM)
CA (1) CA2399640A1 (OSRAM)
CZ (1) CZ20022722A3 (OSRAM)
DE (1) DE60114567T2 (OSRAM)
MX (1) MXPA02007739A (OSRAM)
NO (1) NO20023761L (OSRAM)
NZ (1) NZ520482A (OSRAM)
PL (1) PL356966A1 (OSRAM)
WO (1) WO2001058933A2 (OSRAM)
ZA (1) ZA200206360B (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2497159A1 (en) * 2002-08-30 2004-03-11 K.U. Leuven Research And Development Glycopeptide antibiotic and semisynthetic derivatives thereof and their use as antiviral agents
US8088387B2 (en) * 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
CN1557479A (zh) * 2004-01-16 2004-12-29 深圳市海王英特龙生物技术股份有限公 干扰素脂质体乳膏
US7632918B2 (en) 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
GB2577420B (en) 2017-05-22 2022-07-06 Insmed Inc Glycopeptide derivative compounds and uses thereof
CN108484719A (zh) * 2018-01-19 2018-09-04 四川大学 硫酸酯化十二指肠糖肽制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4643987A (en) * 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
US4639433A (en) * 1985-08-14 1987-01-27 Eli Lilly And Company Glycopeptide derivatives
CA2031803C (en) * 1989-12-13 2001-05-29 Ramakrishnan Nagarajan Improvements in or relating to glycopeptide deriveratives
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
JP4307723B2 (ja) * 1998-05-01 2009-08-05 イーライ リリー アンド カンパニー N1−修飾グリコペプチド

Also Published As

Publication number Publication date
PL356966A1 (en) 2004-07-12
EP1254164A2 (en) 2002-11-06
CN1422279A (zh) 2003-06-04
EP1254164B1 (en) 2005-11-02
NO20023761D0 (no) 2002-08-08
AU2001238180B2 (en) 2005-12-15
AU3818001A (en) 2001-08-20
MXPA02007739A (es) 2002-10-11
DE60114567T2 (de) 2006-07-27
JP2003522197A (ja) 2003-07-22
AU2001238180B8 (en) 2006-07-27
US20070219123A1 (en) 2007-09-20
ATE308560T1 (de) 2005-11-15
CZ20022722A3 (cs) 2003-01-15
KR100796079B1 (ko) 2008-01-21
WO2001058933A3 (en) 2002-02-14
WO2001058933A2 (en) 2001-08-16
HK1049171A1 (en) 2003-05-02
ZA200206360B (en) 2003-11-10
BR0108268A (pt) 2003-03-05
NO20023761L (no) 2002-08-26
CA2399640A1 (en) 2001-08-16
DE60114567D1 (de) 2005-12-08
KR20020073546A (ko) 2002-09-26
US7365053B2 (en) 2008-04-29

Similar Documents

Publication Publication Date Title
NZ529881A (en) Capsular polysaccharide solubilisation and combination vaccines
AU2002306164A1 (en) Composition and method for improving plant growth
AU2002335788A1 (en) Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources
AU2002329885A1 (en) Atmospheric pressure wafer processing reactor having an internal pressure control system and method
PL393939A1 (pl) Środek chwastobójczy, sposób zwalczania niepożądanego wzrostu roślin i zastosowanie kompozycji
ES2131496T3 (es) Mejoras relativas a derivados glicopeptidicos.
MY138285A (en) Fab i inhibitors
AP2001002317A0 (en) Attenuated microorganisms for the treatment of infection
AU4473300A (en) Hair transplantation method and apparatus
NO20023912L (no) Fremgangsmåte for å kontrollere zoologisk og akvatisk plantevekst
CA2369598A1 (fr) Procede de maintien en position d'une piece dans un poste d'assemblage
AU2002312480A1 (en) Operational system for transplanting growing plants
HUP0300585A3 (en) Process for the use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals
WO2001040280A3 (en) Composition and method for treating a microbial infection
AU2003249699A1 (en) Vaccine for the prevention of bacterial infection of the bovine mammary gland
AU7315701A (en) Optically pure(-) clethodim, compositions and methods for controlling plant growth comprising the same
NZ509051A (en) Chemotaxis-inhibiting protein of staphylococcus (CHIPS) and its use
AU2002324753A1 (en) Composition and method for treating viral infection
AU3818001A (en) Selective n-acylation of a82846 glycopeptide analogs
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
GB9920048D0 (en) Epitaxial growth method of III-nitride semiconductors
AU5840301A (en) Method for the processing of plant material
AU7467901A (en) System for culturing marine life and growth device for this purpose
AU2002311352A1 (en) Method for secreting proteins by bacteria, leader sequences and vectors for carrying out said method
AU2002349239A1 (en) Plant growing system

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)